 |
|
CLINICIAN'S CORNER
Aminotransferase Elevations in Healthy Adults Receiving 4 Grams of Acetaminophen Daily
A Randomized Controlled Trial
Paul B. Watkins, MD;
Neil Kaplowitz, MD;
John T. Slattery, PhD;
Connie R. Colonese, MS;
Salvatore V. Colucci, MS;
Paul W. Stewart, PhD;
Stephen C. Harris, MD
JAMA. 2006;296:87-93.
Context During a clinical trial of a novel hydrocodone/acetaminophen combination, a high incidence of serum alanine aminotransferase (ALT) elevations was observed.
Objective To characterize the incidence and magnitude of ALT elevations in healthy participants receiving 4 g of acetaminophen daily, either alone or in combination with selected opioids, as compared with participants treated with placebo.
Design, Setting, and Participants A randomized, single-blind, placebo-controlled, 5-treatment, parallel-group, inpatient, diet-controlled (meals provided), longitudinal study of 145 healthy adults in 2 US inpatient clinical pharmacology units.
Intervention Each participant received either placebo (n = 39), 1 of 3 acetaminophen/opioid combinations (n = 80), or acetaminophen alone (n = 26). Each active treatment included 4 g of acetaminophen daily, the maximum recommended daily dosage. The intended treatment duration was 14 days.
Main Outcomes Serum liver chemistries and trough acetaminophen concentrations measured daily through 8 days, and at 1- or 2-day intervals thereafter.
Results None of the 39 participants assigned to placebo had a maximum ALT of more than 3 times the upper limit of normal. In contrast, the incidence of maximum ALT of more than 3 times the upper limits of normal was 31% to 44% in the 4 treatment groups receiving acetaminophen, including those participants treated with acetaminophen alone. Compared with placebo, treatment with acetaminophen was associated with a markedly higher median maximum ALT (ratio of medians, 2.78; 95% confidence interval, 1.47-4.09; P<.001). Trough acetaminophen concentrations did not exceed therapeutic limits in any participant and, after active treatment was discontinued, often decreased to undetectable levels before ALT elevations resolved.
Conclusions Initiation of recurrent daily intake of 4 g of acetaminophen in healthy adults is associated with ALT elevations and concomitant treatment with opioids does not seem to increase this effect. History of acetaminophen ingestion should be considered in the differential diagnosis of serum aminotransferase elevations, even in the absence of measurable serum acetaminophen concentrations.
Author Affiliations: Department of Medicine, University of North Carolina, Chapel Hill (Dr Watkins); Keck School of Medicine, Department of Medicine, University of Southern California, Los Angeles (Dr Kaplowitz); Departments of Pharmacology and Medicine, University of Washington, Seattle (Dr Slattery); Boehringer-Ingelheim Pharmaceuticals, Inc, Ridgefield, Conn (Ms Colonese); Department of Clinical Pharmacology and Clinical Pharmacokinetics, Purdue Pharma L.P., Stamford, Conn (Mr Colucci and Dr Harris); Deparment of Biostatistics, University of North Carolina, Chapel Hill (Dr Stewart).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED LETTER
Acetaminophen and Aminotransferase Elevations
Yuhong Yuan, Marroon Thabane, Lehana Thabane, and Richard H. Hunt
JAMA. 2006;296(23):2798.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Mouse population-guided resequencing reveals that variants in CD44 contribute to acetaminophen-induced liver injury in humans
Harrill et al.
Genome Res 2009;19:1507-1515.
ABSTRACT
| FULL TEXT
Osteoarthritis: An Update on Data Currently Reshaping Practice
Epstein and Taylor
Journal of Pharmacy Practice 2009;22:75-85.
ABSTRACT
I.V. acetaminophen pharmacokinetics in neonates after multiple doses
Palmer et al.
Br J Anaesth 2008;101:523-530.
ABSTRACT
| FULL TEXT
Acquired Resistance to Acetaminophen Hepatotoxicity is Associated with Induction of Multidrug Resistance-Associated Protein 4 (Mrp4) in Proliferating Hepatocytes
Aleksunes et al.
Toxicol Sci 2008;104:261-273.
ABSTRACT
| FULL TEXT
Blood gene expression signatures predict exposure levels
Bushel et al.
Proc. Natl. Acad. Sci. USA 2007;104:18211-18216.
ABSTRACT
| FULL TEXT
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
Chou et al.
ANN INTERN MED 2007;147:478-491.
ABSTRACT
| FULL TEXT
Glutamate Cysteine Ligase Modifier Subunit Deficiency and Gender as Determinants of Acetaminophen-Induced Hepatotoxicity in Mice
McConnachie et al.
Toxicol Sci 2007;99:628-636.
ABSTRACT
| FULL TEXT
Multicenter Study of Acetaminophen Hepatotoxicity Reveals the Importance of Biological Endpoints in Genomic Analyses
Beyer et al.
Toxicol Sci 2007;99:326-337.
ABSTRACT
| FULL TEXT
A 60-Year-Old Woman Considering Acupuncture for Knee Pain
Berman
JAMA 2007;297:1697-1707.
ABSTRACT
| FULL TEXT
Acetaminophen Protein Adducts in Children With Acute Liver Failure of Indeterminate Cause: In Reply
James et al.
Pediatrics 2007;119:419-420.
FULL TEXT
Acetaminophen and Aminotransferase Elevations
Yuan et al.
JAMA 2006;296:2798-2798.
FULL TEXT
JournalScan
Gut 2006;55:1809-1809.
FULL TEXT
Acetaminophen's maximum dosage yields unexpected result.
Thompson
Am J Health Syst Pharm 2006;63:1581-1582.
FULL TEXT
Is Acetaminophen Still a Good ALTernative?
JWatch Women's Health 2006;2006:1-1.
FULL TEXT
Aminotransferase Elevation in Healthy Adults Taking Acetaminophen
JWatch Emergency Med. 2006;2006:3-3.
FULL TEXT
What's new in the other general journals.
Tonks
BMJ 2006;333:141-142.
FULL TEXT
|
